The Vanguard Group Discloses Stake in Mural Oncology

The Vanguard Group, Inc. has submitted a disclosure under Rule 8.3 of the Irish Takeover Panel Act regarding its stake in Mural Oncology plc. As of June 23, 2025, Vanguard holds 772,995 ordinary shares in Mural Oncology, representing 4.48% of the company. This disclosure follows the takeover rules requiring declarations by entities with a 1% or greater interest in relevant securities.

The disclosure details Vanguard's interests, emphasizing no cash-settled or stock-settled derivatives were involved. Only a minor sale of 16 shares at $2.50 per share was reported. There are no indemnity or dealing arrangements disclosed by Vanguard, nor any agreements concerning options or derivatives related to Mural Oncology.

This move signifies Vanguard's significant position in the oncology firm, as they comply with Irish regulatory frameworks and maintain transparency in their dealings with Mural Oncology's securities.